Sort
27,075 grants matching “cholesterol”
Macrophage SR-BI Regulates Autophagy, Angiogenin and tRNA-derived small RNAs
$532,985Macrae F Linton · Vanderbilt University Medical Center · R01 · FY2019 · HL
Genetic Determinants of Weight Loss and Resolution of Co-Morbidities
$532,980Glenn S Gerhard · Temple Univ Of The Commonwealth · R01 · FY2015 · DK
CD4 helper programs that regulate intratumoral immunity
$532,970Alice Oliffson Kamphorst · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
LXR as a novel therapeutic target in diabetic retinopathy
$532,879Maria B Grant · Indiana University Indianapolis · R01 · FY2016 · EY
Regulation of Sex Differences in Liver Metabolism
$532,861David J Waxman · Boston University (Charles River Campus) · R01 · FY2016 · DK
Impact of the Adipose Tissue Microenvironment on Atherosclerosis
$532,823Willa A. Hsueh · Ohio State University · R01 · FY2018 · HL
Whole genome sequences in ethnically diverse individuals with functional assays and genome editing to characterize the biology of plasma lipids
$532,819Pradeep Natarajan · Massachusetts General Hospital · R01 · FY2022 · HL
Project 3: Metabolic stress induces mitochondrial dysfunction through STARD1 and SAB leading to HCC
$532,804Neil Kaplowitz · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2024 · CA
Apolipoprotein A-l and HDL: Structure, Formation and Function
$532,707David Atkinson · Boston University Medical Campus · R01 · FY2015 · HL
Mechanisms of RPE dysfunction in macular degenerations: role of intracellular complement activation
$532,664Aparna Lakkaraju · University Of California, San Francisco · R01 · FY2023 · EY
Mechanisms of RPE dysfunction in macular degenerations: role of intracellular complement activation
$532,664Aparna Lakkaraju · University Of California, San Francisco · R01 · FY2024 · EY
Systems Genetics of Vascular Smooth Muscle Phenotypes
$532,490Mete Civelek · University Of Virginia · R01 · FY2025 · HL
The UPR and CaMKIIg in Atherosclerosis and Insulin Resistance
$532,486Ira A Tabas · Columbia University Health Sciences · P01 · FY2014 · HL
USE OF MIDLEVEL PROVIDERS IN DIABETES MANAGEMENT
$532,466Patricia J Coon · Billings Clinic Foundation · R18 · FY2007 · DK
Dll4 in macrophage activation
$532,459Masanori Aikawa · Brigham And Women'S Hospital · R01 · FY2015 · HL
Lipoic Acid and Omega-3 Fatty Acids in Alzheimer's Disease
$532,428Lynne H Shinto · Oregon Health & Science University · R01 · FY2010 · AG
Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis
$532,418Yi Tan · University Of Louisville · R01 · FY2025 · HL
Mechanisms of alphavirus infectivity and adaptation - Resubmission - 1
$532,388Kenneth Stapleford · New York University School Of Medicine · R01 · FY2022 · AI
Effect of Pitavastatin on Kidney Function in HIV-infected Persons
$532,330Edgar T Overton · University Of Alabama At Birmingham · R01 · FY2019 · DK
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$532,237Lily Yang · Emory University · R01 · FY2023 · CA
Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis
$532,237Lily Yang · Emory University · R01 · FY2022 · CA
Structural Approches to HIV-1 Immunogen Design for BNAb Generation
$532,178Ellis L Reinherz · Dana-Farber Cancer Inst · U19 · FY2011 · AI
Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II Study
$532,166Bruce Ovbiagele · Northern California Institute/Res/Edu · R01 · FY2022 · NS
Use of High Density Lipoprotein Proteome in the Prediction of Cognitive Impairment and Alzheimer's Disease: (REGARDS)
$532,144Robert Sidney Rosenson · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Dysregulation of PPARα in RPE degeneration
$532,135Jian-Xing Ma · Wake Forest University Health Sciences · R01 · FY2024 · EY